Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
1.
Matern Child Health J ; 20(7): 1375-83, 2016 07.
Article in English | MEDLINE | ID: mdl-26968183

ABSTRACT

Objective To assess the relationship between cortisol slope, a biologic marker of stress, and postpartum weight retention. Methods We included 696 women in a secondary analysis from a multi-site study conducted using principles of community-based participatory research to study multi-level sources of stress on pregnancy outcomes. As a stress marker, we included salivary cortisol slope; the rate of cortisol decline across the day. Pre-pregnancy weight and demographic data were obtained from the medical records. At 6 months postpartum, patients were weighed and returned saliva samples. We built stepwise regression models to assess the effect of demographic variables, cortisol slope and cortisol covariates (wake time, tobacco use and breastfeeding) on postpartum weight retention. Results 45.5 % of participants were African American, 29.2 % White, and 25.3 % Hispanic. Of the Hispanic women 62.5 % were Spanish speaking and 37.5 % were English speaking. In general, participants were young, multiparous, and overweight. Postpartum, almost half (47.6 %) of women studied retained >10 lbs. In multivariable analysis including age, pre-pregnancy BMI and public insurance, cortisol slope was significantly associated with weight retention (ß = -1.90, 95 % CI = 0.22-3.58). However, when the model was adjusted for the cortisol covariates, breastfeeding (ß = -0.63, 95 % CI = -1.01 to -0.24) and public insurance (ß = 0.62, 95 % CI = 0.20-1.04) were the two strongest correlates of weight retention. Conclusions for Practice The association between cortisol slope and postpartum weight retention appears to be influenced breastfeeding status.


Subject(s)
Breast Feeding , Ethnicity/statistics & numerical data , Hydrocortisone/metabolism , Postpartum Period/metabolism , Pregnancy/physiology , Weight Gain , Adolescent , Adult , Breast Feeding/psychology , Community-Based Participatory Research , Cross-Sectional Studies , Ethnicity/psychology , Female , Humans , Postpartum Period/psychology , Pregnancy Outcome , Prospective Studies , Rural Population , Saliva/metabolism , Socioeconomic Factors , Stress, Psychological/psychology , Suburban Population , Urban Population , Young Adult
2.
Am J Obstet Gynecol ; 215(3): 370.e1-6, 2016 09.
Article in English | MEDLINE | ID: mdl-26996988

ABSTRACT

BACKGROUND: Noninvasive prenatal screening has become an increasingly prevalent choice for women who desire aneuploidy screening. Although the test characteristics are impressive, some women are at increased risk for noninvasive prenatal screen failure. The risk of test failure increases with maternal weight; thus, obese women may be at elevated risk for failure. This risk of failure may be mitigated by the addition of a paternal cheek swab and screening at a later gestational age. OBJECTIVE: The purpose of this study was to evaluate the association among obesity, gestational age, and paternal cheek swab in the prevention of screening failure. STUDY DESIGN: A retrospective cohort study was performed for women who were ≥35 years old at delivery who underwent screening at NorthShore University HealthSystem, Evanston, IL. Maternal weight, body mass index, gestational age, and a paternal cheek swab were evaluated in univariate and multivariable logistic regression analyses to assess the association with failed screening. RESULTS: Five hundred sixty-five women met inclusion criteria for our study. The mean body mass index was 25.9 ± 5.1 kg/m(2); 111 women (20%) were obese (body mass index, ≥30 kg/m(2)). Forty-four women (7.8%) had a failed screen. Obese women had a failure rate of 24.3% compared with 3.8% in nonobese women (P < .01). Gestational age was not associated with failure rate (mean ± standard deviation, 13 ± 3 weeks for both screen failure and nonfailure; P = .76). The addition of a paternal cheek swab reduced the failure rate from 10.2% in women with no swab to 3.8% in women with a swab (P < .01). In multivariable analysis, obesity and lack of a paternal cheek swab were independent predictors of screen failure (odds ratio, 9.75; 95% confidence interval, 4.85-19.61; P < .01; and odds ratio, 3.61; 95% confidence interval, 1.56-8.33; P < .01, respectively). CONCLUSION: The addition of a paternal cheek swab significantly improved noninvasive prenatal screen success rates in obese women. However, delaying testing to a later gestational age did not.


Subject(s)
Aneuploidy , DNA/blood , Obesity/complications , Prenatal Diagnosis/adverse effects , Adult , Body Mass Index , Cohort Studies , Fathers , Female , Gestational Age , Humans , Male , Mouth Mucosa/cytology , Multivariate Analysis , Pregnancy , Retrospective Studies
3.
AJP Rep ; 5(2): e099-104, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26495163

ABSTRACT

Objective This study aims to determine if shoulder dystocia is associated with a difference in the fetal abdominal (AC) to head circumference (HC) of 50 mm or more noted on antenatal ultrasound. Study Design A multicenter matched case-control study was performed comparing women who had shoulder dystocia to controls who did not. Women with vaginal births of live born nonanomalous singletons ≥ 36 weeks of gestation with an antenatal ultrasound within 4 weeks of delivery were included. Controls were matched for gestational age, route of delivery, and diabetes status. Results We identified 181 matched pairs. Only 5% of the fetuses had an AC to HC of ≥ 50 mm. The proportion of AC to HC difference of ≥ 50 mm was significantly higher in shoulder dystocia cases (8%) than controls (1%, p = 0.002). With multivariate regression, the three significant factors associated with shoulder dystocia were AC to HC ≥ 50 mm (odds ratio [OR], 7.3; confidence interval [CI], 1.6-33.3; p = 0.010), femur length (OR, 1.1; CI, 1.0-1.2; p = 0.002), and induced labor (OR, 1.8; CI, 1.1-3.1; p = 0.027). Conclusion A prenatal ultrasound finding of a difference in AC to HC of ≥ 50 mm while uncommon is associated with shoulder dystocia.

4.
Obstet Gynecol ; 125(1): 144-152, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25560116

ABSTRACT

OBJECTIVE: To explore risk factors for postpartum weight retention at 1 year after delivery in predominantly low-income women. METHODS: Data were collected from 774 women with complete height and weight information from participants in the Eunice Kennedy Shriver National Institute of Child Health and Human Development Community Child Health Network, a national five-site, prospective cohort study. Participants were enrolled primarily in the hospitals immediately after delivery. Maternal interviews conducted at 1, 6, and 12 months postpartum identified risk factors for weight retention and included direct measurement of height and weight at 6 and 12 months. Logistic regression assessed the independent contribution of postpartum weight retention on obesity. RESULTS: Women had a mean prepregnancy weight of 161.5 lbs (body mass index [BMI] 27.7). Women gained a mean of 32 lbs while pregnant and had a 1-year mean postpartum weight of 172.6 lbs (BMI 29.4). Approximately 75% of women were heavier 1 year postpartum than they were prepregnancy, including 47.4% retaining more than 10 lbs and 24.2% more than 20 lbs. Women retaining at least 20 lbs were more often African American, younger, poor, less educated, or on pubic insurance. Race and socioeconomic disparities were associated with high prepregnancy BMI and excessive weight gain during pregnancy, associations that were attenuated by breastfeeding at 6 months and moderate exercise. Of the 39.8 with normal prepregnancy BMI, one third became overweight or obese 1 year postpartum. CONCLUSION: Postpartum weight retention is a significant contributor to the risk for obesity 1 year postpartum, including for women of normal weight prepregnancy. Postpartum, potentially modifiable behaviors may lower the risk. LEVEL OF EVIDENCE: III.


Subject(s)
Obesity/epidemiology , Postpartum Period , Pregnancy/physiology , Weight Gain , Weight Loss , Adult , Body Mass Index , Breast Feeding , Exercise , Female , Humans , Obesity/ethnology , Prospective Studies , Socioeconomic Factors , Time Factors , Young Adult
5.
Contraception ; 89(6): 534-9, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24457061

ABSTRACT

OBJECTIVE: This trial was designed to compare levonorgestrel intrauterine device (LNG-IUD) use at 1 year after delivery between women randomized to postplacental insertion at the time of cesarean delivery and delayed insertion 4-8 weeks after delivery. STUDY DESIGN: This randomized controlled trial was conducted at two urban medical centers. Eligible pregnant women with planned cesarean deliveries were randomized to immediate postplacental insertion during cesarean or delayed insertion after 4-8 weeks. We used intention-to-treat analysis for the primary outcome of LNG-IUD use 12 months after delivery. RESULTS: Forty-two women were randomized, 20 into the postplacental group and 22 in the delayed group. Although confirmed use of the LNG-IUD 12 months after delivery was higher in the postplacental group (60.0% vs. 40.9%, p=.35), this difference was not statistically significance. Expulsion was significantly more common in the postplacental group (20.0% vs. 0%, p=.04). There were significant differences between the two sites in baseline population characteristics, follow-up and expulsion. The trial did not answer the intended question as it was halted early due to slow enrollment. CONCLUSIONS: Our results show higher expulsion after postplacental insertion compared to delayed insertion but suggest similar IUD use at 12 months. Moreover, it provides valuable lessons regarding a randomized controlled trial of postplacental LNG-IUD placement due to the challenges of estimating effect size and the nature of the population who might benefit from immediate insertion. IMPLICATIONS: Postplacental insertion of an IUD may improve use of highly effective contraception during the postpartum period. While our results suggest higher expulsion after postplacental insertion compared to delayed insertion and similar IUD use at 12 months, our trial was insufficient to definitively test our hypothesis.


Subject(s)
Cesarean Section , Contraceptive Agents, Female/adverse effects , Intrauterine Devices, Medicated/adverse effects , Levonorgestrel/adverse effects , Postnatal Care , Academic Medical Centers , Adult , Chicago , Contraceptive Agents, Female/administration & dosage , Early Termination of Clinical Trials , Female , Follow-Up Studies , Hospitals, Urban , Humans , Intention to Treat Analysis , Intrauterine Device Expulsion/etiology , Levonorgestrel/administration & dosage , Lost to Follow-Up , Patient Satisfaction , Pregnancy , Time Factors , Young Adult
6.
Clin Pharmacokinet ; 53(4): 373-83, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24297680

ABSTRACT

BACKGROUND AND OBJECTIVES: Labetalol is frequently prescribed for the treatment of hypertension during pregnancy; however, the influence of pregnancy on labetalol pharmacokinetics is uncertain, with inconsistent findings reported by previous studies. This study examined the population pharmacokinetics of oral labetalol during and after pregnancy in women receiving labetalol for hypertension. METHODS: Data were collected from 57 women receiving the drug for hypertension from the 12th week of pregnancy through 12 weeks postpartum using a prospective, longitudinal design. A sparse sampling strategy guided collection of plasma samples. Samples were assayed for labetalol by high-performance liquid chromatography. Estimation of population pharmacokinetic parameters and covariate effects was performed by nonlinear mixed effects modeling using NONMEM. The final population model was validated by bootstrap analysis and visual predictive check. Simulations were performed with the final model to evaluate the appropriate body weight to guide labetalol dosing. RESULTS: Lean body weight (LBW) and gestational age, i.e. weeks of pregnancy, were identified as significantly influencing oral clearance (CL/F) of labetalol, with CL/F ranging from 1.4-fold greater than postpartum values at 12 weeks' gestational age to 1.6-fold greater at 40 weeks. Doses adjusted for LBW provide more consistent drug exposure than doses adjusted for total body weight. The apparent volumes of distribution for the central compartment and at steady-state were 1.9-fold higher during pregnancy. CONCLUSIONS: Gestational age and LBW impact the pharmacokinetics of labetalol during pregnancy and have clinical implications for adjusting labetalol doses in these women.


Subject(s)
Antihypertensive Agents/pharmacokinetics , Body Weight/physiology , Gestational Age , Labetalol/pharmacokinetics , Adolescent , Adult , Antihypertensive Agents/therapeutic use , Dose-Response Relationship, Drug , Female , Humans , Hypertension, Pregnancy-Induced/drug therapy , Labetalol/therapeutic use , Longitudinal Studies , Pregnancy , Prospective Studies , Young Adult
7.
Arch. bronconeumol. (Ed. impr.) ; 49(1): 15-21, ene. 2013. ilus, graf, tab
Article in Spanish | IBECS | ID: ibc-107770

ABSTRACT

Antecedentes: Se cree que la lesión pulmonar inducida por el oxígeno conduce al desarrollo de una displasia broncopulmonar en los recién nacidos prematuros. Hemos evaluado los efectos favorables del aceite de Nigella sativa (NSO) en ratas con lesión pulmonar inducida por hiperoxia. Métodos: Se utilizaron 30 ratas Sprague-Dawley recién nacidas a las que se dividió aleatoriamente en 3 grupos para aplicarles hiperoxia (O2 al 95%), hiperoxia+NSO o el grupo de control (O2 al 21%). A las crías del grupo de hiperoxia+NSO se les administró NSO a una dosis de 4ml/kg al día por vía intraperitoneal durante el periodo de estudio. Se realizó una evaluación histopatológica, inmunoquímica y bioquímica (superóxido dismutasa [SOD], glutatión peroxidasa [GSH-Px], malonilaldehído [MDA] y mieloperoxidasa [MPO]). Resultados: En la evaluación histopatológica e inmunoquímica, la gravedad de la lesión pulmonar fue significativamente inferior en el grupo de hiperoxia+NOS (p<0,05). Los niveles tisulares de GSH-Px y SOD se mantuvieron significativamente preservados, y los niveles de MDA y MPO fueron significativamente inferiores en el grupo de hiperoxia+NSO (p<0,05). Conclusión: El NSO redujo significativamente la gravedad de la lesión pulmonar debida a la hiperoxia(AU)


Background: Oxygen-induced lung injury is believed to lead to the development of bronchopulmonary dysplasia in premature infants. We have evaluated the beneficial effects of Nigella sativa oil (NSO) on rats with hyperoxia-induced lung injury. Methods: Thirty newborn Sprague-Dawley rats were randomly divided into 3 groups as hyperoxia (95% O2), hyperoxia+NSO and control (21% O2). Pups in the hyperoxia+NSO group were administered intraperitoneal NSO at a dose of 4ml/kg daily during the study period. Histopathologic, immunochemical, and biochemical evaluations (superoxide dismutase [SOD], glutathione peroxidase [GSH-Px], malonaldehyde [MDA] and myeloperoxidase [MPO]) were performed. Results: In the histopathologic and immunochemical evaluation, severity of lung damage was significantly lower in the hyperoxia+NOS group (P<0.05). Tissue GSH-Px and SOD levels were significantly preserved, and MDA, MPO levels were significantly lower in the hyperoxia+NSO group (P<0.05). Conclusion: NSO significantly reduced the severity of lung damage due to hyperoxia(AU)


Subject(s)
Animals , Rats , Nigella sativa , Phytotherapy , Plant Preparations/therapeutic use , Bronchopulmonary Dysplasia/drug therapy , Lung Injury/chemically induced , Bronchopulmonary Dysplasia/complications , Lung Injury/etiology , Hyperoxia/complications , Oxygen/adverse effects , Bronchopulmonary Dysplasia/chemically induced
8.
Am J Obstet Gynecol ; 196(1): 57.e1-6, 2007 Jan.
Article in English | MEDLINE | ID: mdl-17240234

ABSTRACT

OBJECTIVE: The purpose of this study was to measure the reliability of a model that defines preventability in maternal morbidity and death. STUDY DESIGN: One hundred cases of serious morbidity and death among peripartum women were reviewed by 2 independent groups of medical experts to identify potentially preventable provider or system events that may have led to the progression of illness. RESULTS: Seventy-seven percent of the cases had concordant findings in both groups regarding the identification of any preventable events. Interrater agreement, which was measured by Cohen's Kappa, was 0.49, which suggests moderate to good reliability. Cases with multiple comorbidities, poor documentation, or preventable patient factors tended to have higher levels of disagreement. CONCLUSION: There was high agreement between the 2 groups regarding the identification of preventable events that impact maternal morbidity and death. The reliability of this model for the assessment of preventability is an important step for improvement in obstetric and medical care.


Subject(s)
Maternal Mortality , Models, Statistical , Pregnancy Complications/epidemiology , Pregnancy Complications/prevention & control , Female , Humans , Pregnancy , Reproducibility of Results
9.
Fertil Steril ; 84(4): 975-9, 2005 Oct.
Article in English | MEDLINE | ID: mdl-16213852

ABSTRACT

OBJECTIVE: To estimate the incidence of Sheehan's syndrome in a well-described cohort of patients with obstetric hemorrhage. DESIGN: Retrospective cohort study. SETTING: Tertiary care center. PATIENT(S): Two hundred patients. INTERVENTION(S): Questionnaires were sent to study and comparison patients asking about menstrual dysfunction, lactation difficulty, cold intolerance, fatigue, axillary and pubic hair loss, and secondary infertility. MAIN OUTCOME MEASURE(S): Women who experienced two or more symptoms were referred for hormone testing of insulin-like growth factor 1 (IGF-1), T4, PRL, and early morning cortisol (F) levels. RESULT(S): A total of 109 patients responded to the survey, a 55% response rate. Fourteen of 55 (25%) patients in the hemorrhage group identified themselves as suffering from two or more symptoms on the questionnaire. Eight of the 14 patients were tested, but none had hormonal evidence of hypopituitarism. Four of 54 (7%) comparison patients also identified themselves as suffering from two or more symptoms, but neither of the two tested had hormonal evidence of hypopituitarism. CONCLUSION(S): Among women with postpartum hemorrhage, subsequent development of clinical symptoms does not correlate well with laboratory evidence of hypopituitarism. Clinically significant Sheehan syndrome is an uncommon consequence of obstetric hemorrhage in today's environment.


Subject(s)
Hypopituitarism/epidemiology , Hypopituitarism/physiopathology , Labor, Obstetric , Parturition , Postpartum Hemorrhage/epidemiology , Adult , Cohort Studies , Confidence Intervals , Female , Humans , Incidence , Philadelphia , Pregnancy
10.
Clin Perinatol ; 32(2): 301-14, v, 2005 Jun.
Article in English | MEDLINE | ID: mdl-15922784

ABSTRACT

Twins have always aroused interest and have been represented throughout history. Conjoined twins have caused even more sensation, the best-known pair being Chang and Eng Bunker, who were born in Thailand in 1811 and inspired the term Siamese twins. Recently, higher-order multiples have caused controversy, and there has been heavy media coverage of large-number deliveries, such as the McCaughey septuplets. In this article, we review the incidence, types, and causes of multiple gestations.


Subject(s)
Pregnancy, Multiple/physiology , Pregnancy, Multiple/statistics & numerical data , Biology , Female , Humans , Incidence , Pregnancy , Pregnancy Outcome , Twins/physiology
11.
Am J Perinatol ; 21(8): 477-81, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15580544

ABSTRACT

Serum levels of interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF-alpha) were measured in patients requiring an emergent cerclage to determine if they are predictive of successful pregnancy outcome. Women with a clinical diagnosis of cervical incompetence requiring an emergent cerclage between 15 and 24 weeks gestation were enrolled. Asymptomatic women of the same gestational age range were recruited as controls. IL-6 and TNF-alpha levels were measured by enzyme-linked immunosorbent assay. Twenty-one women underwent emergent cerclage and participated in the study, 15 (71%) of whom delivered after 28 weeks. Twenty-one women served as controls. IL-6 levels were increased in women with cervical incompetence compared with control subjects, but there were no differences between cerclage success and failure groups. TNF-alpha was not increased in women with cervical incompetence and did not predict success of emergent cerclage. IL-6 levels were increased in women with cervical incompetence who required an emergent cerclage.


Subject(s)
Cerclage, Cervical , Interleukin-6/blood , Tumor Necrosis Factor-alpha/metabolism , Uterine Cervical Incompetence/surgery , Adult , Biomarkers , Case-Control Studies , Cohort Studies , Female , Humans , Pregnancy , Pregnancy Trimester, Second , Prospective Studies , Treatment Outcome
12.
Diabetes Care ; 27(2): 331-4, 2004 Feb.
Article in English | MEDLINE | ID: mdl-14747209

ABSTRACT

OBJECTIVE: We investigated the association between functional health literacy and markers of pregnancy preparedness in women with pregestational diabetes. RESEARCH DESIGN AND METHODS: English- and Spanish-speaking pregnant women with pregestational diabetes were recruited. Women completed the Test of Functional Health Literacy in Adults (TOFHLA) short form and a questionnaire. A TOFHLA score of < or =30 was defined as low functional health literacy. RESULTS: Of 74 women participating in the study, 16 (22%) were classified as having low functional health literacy. Compared with women with adequate health literacy, those with low health literacy were significantly more likely to have an unplanned pregnancy (P = 0.02) and significantly less likely to have either discussed pregnancy ahead of time with an endocrinologist or obstetrician (P = 0.01) or taken folic acid (P = 0.001). CONCLUSIONS: The results of this study suggest that low functional health literacy among women with pregestational diabetes is associated with several factors that may adversely impact birth outcomes.


Subject(s)
Attitude to Health , Diabetes Mellitus/psychology , Diabetes, Gestational/psychology , Health Knowledge, Attitudes, Practice , Patient Education as Topic , Pregnancy/psychology , Adult , Chicago , Cross-Sectional Studies , Diabetes Mellitus/rehabilitation , Diabetes, Gestational/rehabilitation , Female , Humans , Language , Racial Groups
13.
Am J Obstet Gynecol ; 189(3): 755-7, 2003 Sep.
Article in English | MEDLINE | ID: mdl-14526308

ABSTRACT

OBJECTIVE: We investigated whether low human chorionic gonadotropin from maternal serum screening is associated with adverse pregnancy outcome. STUDY DESIGN: Women between 15 and 20 completed weeks of gestation who had a maternal serum screen performed from June 1999 to November 2001 were studied. Cases included women with human chorionic gonadotropin values of 0.5 and <2.0 multiples of the median, and estriol values of >0.6 and <2.0 multiples of the median. Control subjects were selected randomly from the population of women with normal values for all three analytes. RESULTS: There were 146 case subjects and 292 control subjects. There was no increased risk in the study group compared with the control subjects for preterm delivery, intrauterine fetal death, low birth weight, abruptio placentae, preeclampsia, or preterm premature rupture of membranes. CONCLUSION: An isolated low human chorionic gonadotropin level from second-trimester maternal serum screening is not associated with adverse pregnancy outcome.


Subject(s)
Chorionic Gonadotropin, beta Subunit, Human/blood , Gestational Age , Pregnancy Outcome , Abruptio Placentae/epidemiology , Birth Weight , Estriol/blood , Female , Fetal Death/epidemiology , Fetal Membranes, Premature Rupture/epidemiology , Humans , Infant, Newborn , Obstetric Labor, Premature/epidemiology , Pre-Eclampsia/epidemiology , Pregnancy , Pregnancy Trimester, Second , alpha-Fetoproteins/analysis
14.
Am J Perinatol ; 20(3): 109-13, 2003 Apr.
Article in English | MEDLINE | ID: mdl-12802709

ABSTRACT

The guanine to adenine substitution at the -308 position in the tumor necrosis factor-alpha (TNF-alpha) gene promoter region results in a 5-fold greater cytokine response to an inciting event. We investigated whether this polymorphism is associated with cervical incompetence and adverse pregnancy outcome after emergent cerclage. Women with a diagnosis of cervical incompetence requiring an emergent cerclage between 15 and 24 weeks were enrolled. Women without pregnancy complications were recruited as controls. DNA extraction from peripheral blood and polymerase chain reaction (PCR) amplification of a 144-base pair segment of the TNF-alpha gene were performed with subsequent sequencing. Twenty-three women underwent emergent cerclage and participated in the study, 13 (57%) of whom delivered after 28 weeks. Twenty-three women served as controls. There were no differences in the TNF-alpha polymorphism between women with cervical incompetence and controls or between women with cervical incompetence who delivered before versus after 28 weeks. The TNF-alpha polymorphism was not associated with cervical incompetence or with delivery prior to 28 weeks in women who received an emergent cerclage.


Subject(s)
Cerclage, Cervical , Polymorphism, Genetic/physiology , Tumor Necrosis Factor-alpha/genetics , Uterine Cervical Incompetence/genetics , Adult , Cohort Studies , Female , Genotype , Gestational Age , Humans , Polymorphism, Genetic/genetics , Pregnancy , Pregnancy Outcome , Pregnancy Trimester, Second , Prospective Studies , Treatment Outcome , Uterine Cervical Incompetence/prevention & control
SELECTION OF CITATIONS
SEARCH DETAIL
...